Actively Recruiting
The Effect of Standardizing Procedures for Subcutaneous Injections of Low-molecular-weight Heparin on Patients With Cardiovascular Diseases: A Cluster Randomized Controlled Trial
Led by The Hong Kong Polytechnic University · Updated on 2025-09-11
180
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
CONDITIONS
Brief Title
The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
- Chinese
You will not qualify if you...
- cognitively impaired
- unconscious
- refuse to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Authority, Hong Kong
Hong Kong, Hong Kong, 00000
Actively Recruiting
Research Team
F
Frankie CHEUNG
A
Arkers Wong
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here